Annual Cash & Cash Equivalents
$21.84 M
-$24.32 M-52.69%
December 31, 2022
Summary
- As of February 9, 2025, BLCM annual cash & cash equivalents is $21.84 million, with the most recent change of -$24.32 million (-52.69%) on December 31, 2022.
- During the last 3 years, BLCM annual cash & cash equivalents has fallen by -$69.19 million (-76.01%).
Performance
BLCM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.91 M
-$1.50 M-20.26%
September 1, 2023
Summary
- As of February 9, 2025, BLCM quarterly cash and cash equivalents is $5.91 million, with the most recent change of -$1.50 million (-20.26%) on September 1, 2023.
- Over the past year, BLCM quarterly cash and cash equivalents has dropped by -$22.85 million (-79.45%).
Performance
BLCM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BLCM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.7% | -79.5% |
| 3 y3 years | -76.0% | -88.9% |
| 5 y5 years | -43.8% | -88.9% |
BLCM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -52.7% | at low | -87.2% | at low |
| 5 y | 5-year | -76.0% | at low | -93.5% | at low |
| alltime | all time | -88.6% | -92.5% | -96.9% | at low |
Bellicum Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $5.91 M(-20.3%) |
| Jun 2023 | - | $7.41 M(-51.9%) |
| Mar 2023 | - | $15.40 M(-29.5%) |
| Dec 2022 | $21.84 M(-52.7%) | $21.84 M(-24.1%) |
| Sep 2022 | - | $28.76 M(-13.3%) |
| Jun 2022 | - | $33.17 M(-16.6%) |
| Mar 2022 | - | $39.77 M(-13.8%) |
| Dec 2021 | $46.16 M(+30.0%) | $46.16 M(+139.6%) |
| Sep 2021 | - | $19.27 M(-5.0%) |
| Jun 2021 | - | $20.28 M(-27.8%) |
| Mar 2021 | - | $28.08 M(-20.9%) |
| Dec 2020 | $35.49 M(-61.0%) | $35.49 M(-33.2%) |
| Sep 2020 | - | $53.13 M(-20.0%) |
| Jun 2020 | - | $66.41 M(-10.9%) |
| Mar 2020 | - | $74.56 M(-18.1%) |
| Dec 2019 | $91.03 M(+108.3%) | $91.03 M(-8.2%) |
| Sep 2019 | - | $99.15 M(+131.4%) |
| Jun 2019 | - | $42.86 M(+1.4%) |
| Mar 2019 | - | $42.27 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $43.70 M(+12.5%) | $43.70 M(-17.6%) |
| Sep 2018 | - | $53.03 M(-27.8%) |
| Jun 2018 | - | $73.46 M(+131.0%) |
| Mar 2018 | - | $31.79 M(-18.1%) |
| Dec 2017 | $38.84 M(+17.2%) | $38.84 M(-28.7%) |
| Sep 2017 | - | $54.47 M(-27.5%) |
| Jun 2017 | - | $75.15 M(-22.2%) |
| Mar 2017 | - | $96.64 M(+191.6%) |
| Dec 2016 | $33.14 M(-52.8%) | $33.14 M(-31.9%) |
| Sep 2016 | - | $48.69 M(-1.7%) |
| Jun 2016 | - | $49.55 M(-19.8%) |
| Mar 2016 | - | $61.79 M(-12.0%) |
| Dec 2015 | $70.24 M(-63.3%) | $70.24 M(-24.1%) |
| Sep 2015 | - | $92.49 M(-9.0%) |
| Jun 2015 | - | $101.65 M(-44.6%) |
| Mar 2015 | - | $183.64 M(-4.2%) |
| Dec 2014 | $191.60 M(+1615.7%) | $191.60 M(+209.4%) |
| Sep 2014 | - | $61.93 M(+454.6%) |
| Dec 2013 | $11.17 M(+584.2%) | $11.17 M |
| Dec 2012 | $1.63 M | - |
FAQ
- What is Bellicum Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Bellicum Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Bellicum Pharmaceuticals?
- What is Bellicum Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Bellicum Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of BLCM is $21.84 M
What is the all time high annual cash & cash equivalents for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high annual cash & cash equivalents is $191.60 M
What is Bellicum Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, BLCM annual cash & cash equivalents has changed by -$24.32 M (-52.69%)
What is Bellicum Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BLCM is $5.91 M
What is the all time high quarterly cash and cash equivalents for Bellicum Pharmaceuticals?
Bellicum Pharmaceuticals all-time high quarterly cash and cash equivalents is $191.60 M
What is Bellicum Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, BLCM quarterly cash and cash equivalents has changed by -$22.85 M (-79.45%)